Lisa Gill
Stock Analyst at JP Morgan
(2.38)
# 2,523
Out of 5,182 analysts
141
Total ratings
43.16%
Success rate
-0.33%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Neutral | $9 → $7 | $5.32 | +31.58% | 10 | Mar 13, 2026 | |
| MDLN Medline | Maintains: Overweight | $50 → $53 | $43.12 | +22.91% | 2 | Mar 10, 2026 | |
| GDRX GoodRx Holdings | Downgrades: Neutral | n/a | $2.05 | - | 3 | Feb 27, 2026 | |
| LH Labcorp Holdings | Maintains: Overweight | $319 → $330 | $269.17 | +22.60% | 4 | Feb 18, 2026 | |
| CAH Cardinal Health | Maintains: Neutral | $209 → $243 | $212.77 | +14.21% | 7 | Feb 10, 2026 | |
| COR Cencora | Maintains: Overweight | $417 → $419 | $320.89 | +30.57% | 4 | Feb 10, 2026 | |
| MCK McKesson | Maintains: Overweight | $983 → $1,107 | $856.62 | +29.23% | 15 | Feb 10, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $394 → $397 | $311.83 | +27.31% | 7 | Feb 2, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $425 → $389 | $307.73 | +26.41% | 11 | Feb 2, 2026 | |
| CVS CVS Health | Maintains: Overweight | $93 → $101 | $78.22 | +29.12% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $23 | $21.66 | +6.19% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $32 → $33 | $22.38 | +47.45% | 6 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $25 → $26 | $17.16 | +51.52% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $428 → $375 | $274.25 | +36.74% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 → $10 | $6.45 | +55.04% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $196.81 | -3.46% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $30 | $21.33 | +40.65% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $41 | $27.74 | +47.80% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $257 → $256 | $197.15 | +29.85% | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $32.45 | -44.53% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $7.89 | -36.63% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $12.64 | +121.52% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $9.02 | +99.56% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $141.53 | +179.09% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $180.61 | +2.98% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $194.60 | -28.06% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $489.58 | -32.19% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $425 → $225 | $16.59 | +1,256.24% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $6.41 | +24.80% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $73.85 | +12.39% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $36.31 | +169.90% | 1 | Jan 6, 2023 |
Teladoc Health
Mar 13, 2026
Maintains: Neutral
Price Target: $9 → $7
Current: $5.32
Upside: +31.58%
Medline
Mar 10, 2026
Maintains: Overweight
Price Target: $50 → $53
Current: $43.12
Upside: +22.91%
GoodRx Holdings
Feb 27, 2026
Downgrades: Neutral
Price Target: n/a
Current: $2.05
Upside: -
Labcorp Holdings
Feb 18, 2026
Maintains: Overweight
Price Target: $319 → $330
Current: $269.17
Upside: +22.60%
Cardinal Health
Feb 10, 2026
Maintains: Neutral
Price Target: $209 → $243
Current: $212.77
Upside: +14.21%
Cencora
Feb 10, 2026
Maintains: Overweight
Price Target: $417 → $419
Current: $320.89
Upside: +30.57%
McKesson
Feb 10, 2026
Maintains: Overweight
Price Target: $983 → $1,107
Current: $856.62
Upside: +29.23%
Elevance Health
Feb 2, 2026
Maintains: Overweight
Price Target: $394 → $397
Current: $311.83
Upside: +27.31%
UnitedHealth Group
Feb 2, 2026
Maintains: Overweight
Price Target: $425 → $389
Current: $307.73
Upside: +26.41%
CVS Health
Dec 17, 2025
Maintains: Overweight
Price Target: $93 → $101
Current: $78.22
Upside: +29.12%
Dec 17, 2025
Maintains: Overweight
Price Target: $20 → $23
Current: $21.66
Upside: +6.19%
Nov 13, 2025
Maintains: Overweight
Price Target: $32 → $33
Current: $22.38
Upside: +47.45%
Nov 11, 2025
Maintains: Neutral
Price Target: $25 → $26
Current: $17.16
Upside: +51.52%
Nov 4, 2025
Maintains: Overweight
Price Target: $428 → $375
Current: $274.25
Upside: +36.74%
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $6.45
Upside: +55.04%
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $196.81
Upside: -3.46%
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $21.33
Upside: +40.65%
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $27.74
Upside: +47.80%
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $197.15
Upside: +29.85%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $32.45
Upside: -44.53%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $7.89
Upside: -36.63%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $12.64
Upside: +121.52%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $9.02
Upside: +99.56%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $141.53
Upside: +179.09%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $180.61
Upside: +2.98%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $194.60
Upside: -28.06%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $489.58
Upside: -32.19%
Jan 5, 2024
Downgrades: Neutral
Price Target: $425 → $225
Current: $16.59
Upside: +1,256.24%
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $6.41
Upside: +24.80%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $73.85
Upside: +12.39%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $36.31
Upside: +169.90%